project id: TCGA-LIHC; case submitter id: TCGA-HP-A5N0; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.25; rna integrity number: 7.5; age at index: 90; days to birth: -32120; days to death: 752; ethnicity: not reported; gender: female; race: not reported; vital status: Dead; age at diagnosis: 32120; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic t: TX; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C22.0; last known disease status: not reported; morphology: 8174/3; primary diagnosis: Hepatocellular carcinoma, clear cell type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Liver; synchronous malignancy: No; tissue or organ of origin: Liver; tumor grade: Not Reported; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 350.0; portion submitter id: TCGA-HP-A5N0-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 90.0;